Clinical Trial Update: Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 multinational trial evaluating the efficacy and safety of inhaled treprostinil in idiopathic pulmonary fibrosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Interstitial Lung Disease

Drugs mentioned

• Tyvaso (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease | Phase 3 | Status: COMPLETED